收案條件

Inclusion
Histologically confirmed, unresectable advanced or metastatic biliary tract, including cholangiocarcinoma (intrahepatic or extrahepatic) and gallbladder carcinoma.
Patients with previously untreated disease if unresectable or metastatic at initial diagnosis will be eligible.
Patient with recurrent disease \>6 months after curative surgery or \>6 months after the completion of adjuvant therapy (chemotherapy and/or radiation) will be eligible.
WHO/ECOG PS of 0 or 1
Exclusion
History of another primary malignancy
Brain metastases or spinal cord compression
Uncontrolled intercurrent illness
Major surgical procedure within 28 days prior to the first dose of IP.
Prior locoregional therapy such as radioembolization

收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。